APO Research
Talk to an analyst

APO RESEARCH · REPORT

Multi-disease Fundus Imaging-assisted Diagnostic System

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Outlook and Growth Opportunities 2026

12 August 2026207 pages

Choose your research edition.

Industry ResearchMulti-disease Fundus Imaging-assisted Diagnostic System Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Multi-disease Fundus Imaging-assisted Diagnostic System Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Multi-disease Fundus Imaging-assisted Diagnostic System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Multi-disease Fundus Imaging-assisted Diagnostic System Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Multi-disease Fundus Imaging-assisted Diagnostic System Market Analysis and Forecast 2026-2032184 pages · $4,950 USD

Market perspective

The global Multi-disease Fundus Imaging-assisted Diagnostic System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Multi-disease Fundus Imaging-assisted Diagnostic System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Multi-disease Fundus Imaging-assisted Diagnostic System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Multi-disease Fundus Imaging-assisted Diagnostic System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Multi-disease Fundus Imaging-assisted Diagnostic System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Multi-disease Fundus Imaging-assisted Diagnostic System market include Remidio, RetinAI, RetinaRisk, Eyenuk, Inc., Intelligent Retinal Imaging Systems, Retmarker, CSIRO, WeDoctor Group and VoxelCloud, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Multi-disease Fundus Imaging-assisted Diagnostic System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Multi-disease Fundus Imaging-assisted Diagnostic System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Multi-disease Fundus Imaging-assisted Diagnostic System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Multi-disease Fundus Imaging-assisted Diagnostic System market.

Multi-disease Fundus Imaging-assisted Diagnostic System Segment by Company

Remidio

RetinAI

RetinaRisk

Eyenuk, Inc.

Intelligent Retinal Imaging Systems

Retmarker

CSIRO

WeDoctor Group

VoxelCloud

Zhenhealth

Tencent Health

Airdoc

Silicon Intelligence

Zhiyuan Huitu

Kangfuzi Health

AEYE Health

RetinaLyze

DeepMind

Multi-disease Fundus Imaging-assisted Diagnostic System Segment by Type

On-premise

Cloud-based

Multi-disease Fundus Imaging-assisted Diagnostic System Segment by Application

Hospitals

Clinics

Multi-disease Fundus Imaging-assisted Diagnostic System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Multi-disease Fundus Imaging-assisted Diagnostic System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Multi-disease Fundus Imaging-assisted Diagnostic System key companies, revenue, market share, and recent developments.

3. To split the Multi-disease Fundus Imaging-assisted Diagnostic System breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Multi-disease Fundus Imaging-assisted Diagnostic System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Multi-disease Fundus Imaging-assisted Diagnostic System significant trends, drivers, influence factors in global and regions.

6. To analyze Multi-disease Fundus Imaging-assisted Diagnostic System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multi-disease Fundus Imaging-assisted Diagnostic System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multi-disease Fundus Imaging-assisted Diagnostic System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multi-disease Fundus Imaging-assisted Diagnostic System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Multi-disease Fundus Imaging-assisted Diagnostic System industry.

Chapter 3: Detailed analysis of Multi-disease Fundus Imaging-assisted Diagnostic System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Multi-disease Fundus Imaging-assisted Diagnostic System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Multi-disease Fundus Imaging-assisted Diagnostic System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Multi-disease Fundus Imaging-assisted Diagnostic System Industry Trends Table 2. Multi-disease Fundus Imaging-assisted Diagnostic System Industry Drivers Table 3. Multi-disease Fundus Imaging-assisted Diagnostic System Industry Opportunities and Challenges Table 4. Multi-disease Fundus Imaging-assisted Diagnostic System Industry Restraints Table 5. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Share by Company (2021-2026) Table 7. Global Multi-disease Fundus Imaging-assisted Diagnostic System Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Multi-disease Fundus Imaging-assisted Diagnostic System Key Company Manufacturing Base & Headquarters Table 9. Global Multi-disease Fundus Imaging-assisted Diagnostic System Company, Product Type & Application Table 10. Global Multi-disease Fundus Imaging-assisted Diagnostic System Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Multi-disease Fundus Imaging-assisted Diagnostic System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On-premise Table 15. Significant Companies of Cloud-based Table 16. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type (2021-2026) Table 20. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of Clinics Table 23. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application (2021-2026) Table 27. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application (2027-2032) Table 28. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Region (2021-2026) Table 31. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Region (2027-2032) Table 33. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Market Share by Country (2021-2026) Table 36. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Market Share by Country (2027-2032) Table 38. Remidio Company Information Table 39. Remidio Business Overview Table 40. Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 42. Remidio Recent Development Table 43. RetinAI Company Information Table 44. RetinAI Business Overview Table 45. RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 47. RetinAI Recent Development Table 48. RetinaRisk Company Information Table 49. RetinaRisk Business Overview Table 50. RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 52. RetinaRisk Recent Development Table 53. Eyenuk, Inc. Company Information Table 54. Eyenuk, Inc. Business Overview Table 55. Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 57. Eyenuk, Inc. Recent Development Table 58. Intelligent Retinal Imaging Systems Company Information Table 59. Intelligent Retinal Imaging Systems Business Overview Table 60. Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 62. Intelligent Retinal Imaging Systems Recent Development Table 63. Retmarker Company Information Table 64. Retmarker Business Overview Table 65. Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 67. Retmarker Recent Development Table 68. CSIRO Company Information Table 69. CSIRO Business Overview Table 70. CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 72. CSIRO Recent Development Table 73. WeDoctor Group Company Information Table 74. WeDoctor Group Business Overview Table 75. WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 77. WeDoctor Group Recent Development Table 78. VoxelCloud Company Information Table 79. VoxelCloud Business Overview Table 80. VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 82. VoxelCloud Recent Development Table 83. Zhenhealth Company Information Table 84. Zhenhealth Business Overview Table 85. Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 87. Zhenhealth Recent Development Table 88. Tencent Health Company Information Table 89. Tencent Health Business Overview Table 90. Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 92. Tencent Health Recent Development Table 93. Airdoc Company Information Table 94. Airdoc Business Overview Table 95. Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 97. Airdoc Recent Development Table 98. Silicon Intelligence Company Information Table 99. Silicon Intelligence Business Overview Table 100. Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 102. Silicon Intelligence Recent Development Table 103. Zhiyuan Huitu Company Information Table 104. Zhiyuan Huitu Business Overview Table 105. Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 107. Zhiyuan Huitu Recent Development Table 108. Kangfuzi Health Company Information Table 109. Kangfuzi Health Business Overview Table 110. Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 112. Kangfuzi Health Recent Development Table 113. AEYE Health Company Information Table 114. AEYE Health Business Overview Table 115. AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 117. AEYE Health Recent Development Table 118. RetinaLyze Company Information Table 119. RetinaLyze Business Overview Table 120. RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 122. RetinaLyze Recent Development Table 123. DeepMind Company Information Table 124. DeepMind Business Overview Table 125. DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 127. DeepMind Recent Development Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Multi-disease Fundus Imaging-assisted Diagnostic System Product Image Figure 2. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (2021-2032) & (US$ Million) Figure 4. Global Multi-disease Fundus Imaging-assisted Diagnostic System Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On-premise Image Figure 8. Cloud-based Image Figure 9. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. Clinics Image Figure 14. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application (2021-2032) Figure 17. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value (2021-2032) & (US$ Million) Figure 20. North America Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value (2021-2032) & (US$ Million) Figure 26. South America Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • On-premise
  • Cloud-based
Applications
  • Hospitals
  • Clinics
Companies covered
  • Remidio
  • RetinAI
  • RetinaRisk
  • Eyenuk, Inc.
  • Intelligent Retinal Imaging Systems
  • Retmarker
  • CSIRO
  • WeDoctor Group
  • VoxelCloud
  • Zhenhealth
  • Tencent Health
  • Airdoc
  • Silicon Intelligence
  • Zhiyuan Huitu
  • Kangfuzi Health
  • AEYE Health
  • RetinaLyze
  • DeepMind

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Multi-disease Fundus Imaging-assisted Diagnostic System Market Dynamics
  1. 2.1 Multi-disease Fundus Imaging-assisted Diagnostic System Industry Trends
  2. 2.2 Multi-disease Fundus Imaging-assisted Diagnostic System Industry Drivers
  3. 2.3 Multi-disease Fundus Imaging-assisted Diagnostic System Industry Opportunities and Challenges
  4. 2.4 Multi-disease Fundus Imaging-assisted Diagnostic System Industry Restraints
3 Multi-disease Fundus Imaging-assisted Diagnostic System Market by Company
  1. 3.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Company Revenue Ranking in 2025
  2. 3.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Company (2021-2026)
  3. 3.3 Global Multi-disease Fundus Imaging-assisted Diagnostic System Company Ranking (2024-2026)
  4. 3.4 Global Multi-disease Fundus Imaging-assisted Diagnostic System Company Manufacturing Base and Headquarters
  5. 3.5 Global Multi-disease Fundus Imaging-assisted Diagnostic System Company Product Type and Application
  6. 3.6 Global Multi-disease Fundus Imaging-assisted Diagnostic System Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Multi-disease Fundus Imaging-assisted Diagnostic System Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Multi-disease Fundus Imaging-assisted Diagnostic System Market by Type
  1. 4.1 Multi-disease Fundus Imaging-assisted Diagnostic System Type Introduction
  2. 4.1.1 On-premise
  3. 4.1.2 Cloud-based
  4. 4.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Type
  5. 4.2.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Type (2021-2032)
  7. 4.2.3 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type (2021-2032)
5 Multi-disease Fundus Imaging-assisted Diagnostic System Market by Application
  1. 5.1 Multi-disease Fundus Imaging-assisted Diagnostic System Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Application
  5. 5.2.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Application (2021-2032)
  7. 5.2.3 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application (2021-2032)
6 Multi-disease Fundus Imaging-assisted Diagnostic System Regional Value Analysis
  1. 6.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Region (2021-2032)
  3. 6.2.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Region: 2021-2026
  4. 6.2.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value (2021-2032)
  7. 6.3.2 North America Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value (2021-2032)
  10. 6.4.2 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value (2021-2032)
  16. 6.6.2 South America Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Country, 2025 VS 2032
7 Multi-disease Fundus Imaging-assisted Diagnostic System Country-level Value Analysis
  1. 7.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Country (2021-2032)
  3. 7.2.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Country (2021-2026)
  4. 7.2.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Multi-disease Fundus Imaging-assisted Diagnostic System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Remidio
  2. 8.1.1 Remidio Company Information
  3. 8.1.2 Remidio Business Overview
  4. 8.1.3 Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  6. 8.1.5 Remidio Recent Developments
  7. 8.2 RetinAI
  8. 8.2.1 RetinAI Company Information
  9. 8.2.2 RetinAI Business Overview
  10. 8.2.3 RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  11. 8.2.4 RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  12. 8.2.5 RetinAI Recent Developments
  13. 8.3 RetinaRisk
  14. 8.3.1 RetinaRisk Company Information
  15. 8.3.2 RetinaRisk Business Overview
  16. 8.3.3 RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  17. 8.3.4 RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  18. 8.3.5 RetinaRisk Recent Developments
  19. 8.4 Eyenuk, Inc.
  20. 8.4.1 Eyenuk, Inc. Company Information
  21. 8.4.2 Eyenuk, Inc. Business Overview
  22. 8.4.3 Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  24. 8.4.5 Eyenuk, Inc. Recent Developments
  25. 8.5 Intelligent Retinal Imaging Systems
  26. 8.5.1 Intelligent Retinal Imaging Systems Company Information
  27. 8.5.2 Intelligent Retinal Imaging Systems Business Overview
  28. 8.5.3 Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  30. 8.5.5 Intelligent Retinal Imaging Systems Recent Developments
  31. 8.6 Retmarker
  32. 8.6.1 Retmarker Company Information
  33. 8.6.2 Retmarker Business Overview
  34. 8.6.3 Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  36. 8.6.5 Retmarker Recent Developments
  37. 8.7 CSIRO
  38. 8.7.1 CSIRO Company Information
  39. 8.7.2 CSIRO Business Overview
  40. 8.7.3 CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  42. 8.7.5 CSIRO Recent Developments
  43. 8.8 WeDoctor Group
  44. 8.8.1 WeDoctor Group Company Information
  45. 8.8.2 WeDoctor Group Business Overview
  46. 8.8.3 WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  47. 8.8.4 WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  48. 8.8.5 WeDoctor Group Recent Developments
  49. 8.9 VoxelCloud
  50. 8.9.1 VoxelCloud Company Information
  51. 8.9.2 VoxelCloud Business Overview
  52. 8.9.3 VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  53. 8.9.4 VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  54. 8.9.5 VoxelCloud Recent Developments
  55. 8.10 Zhenhealth
  56. 8.10.1 Zhenhealth Company Information
  57. 8.10.2 Zhenhealth Business Overview
  58. 8.10.3 Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  60. 8.10.5 Zhenhealth Recent Developments
  61. 8.11 Tencent Health
  62. 8.11.1 Tencent Health Company Information
  63. 8.11.2 Tencent Health Business Overview
  64. 8.11.3 Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  66. 8.11.5 Tencent Health Recent Developments
  67. 8.12 Airdoc
  68. 8.12.1 Airdoc Company Information
  69. 8.12.2 Airdoc Business Overview
  70. 8.12.3 Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  72. 8.12.5 Airdoc Recent Developments
  73. 8.13 Silicon Intelligence
  74. 8.13.1 Silicon Intelligence Company Information
  75. 8.13.2 Silicon Intelligence Business Overview
  76. 8.13.3 Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  78. 8.13.5 Silicon Intelligence Recent Developments
  79. 8.14 Zhiyuan Huitu
  80. 8.14.1 Zhiyuan Huitu Company Information
  81. 8.14.2 Zhiyuan Huitu Business Overview
  82. 8.14.3 Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  84. 8.14.5 Zhiyuan Huitu Recent Developments
  85. 8.15 Kangfuzi Health
  86. 8.15.1 Kangfuzi Health Company Information
  87. 8.15.2 Kangfuzi Health Business Overview
  88. 8.15.3 Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  90. 8.15.5 Kangfuzi Health Recent Developments
  91. 8.16 AEYE Health
  92. 8.16.1 AEYE Health Company Information
  93. 8.16.2 AEYE Health Business Overview
  94. 8.16.3 AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  95. 8.16.4 AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  96. 8.16.5 AEYE Health Recent Developments
  97. 8.17 RetinaLyze
  98. 8.17.1 RetinaLyze Company Information
  99. 8.17.2 RetinaLyze Business Overview
  100. 8.17.3 RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  101. 8.17.4 RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  102. 8.17.5 RetinaLyze Recent Developments
  103. 8.18 DeepMind
  104. 8.18.1 DeepMind Company Information
  105. 8.18.2 DeepMind Business Overview
  106. 8.18.3 DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  107. 8.18.4 DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  108. 8.18.5 DeepMind Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst